Asymchem Laboratories (Tianjin) Co., Ltd.
XSEC:002821 Rapporto sulle azioni
Cap. di mercato: CN¥31.5b
Aggiungi alla lista di controlloAsymchem Laboratories (Tianjin) Dividendi e riacquisti
Dividendo criteri di controllo 2/6 Asymchem Laboratories (Tianjin) è una società che paga dividendi con un rendimento attuale pari a 1.97%, ben coperto dagli utili.
Informazioni chiave
2.0%
Rendimento del dividendo
4.0%
Rendimento del riacquisto
Rendimento totale per gli azionisti 5.9% Rendimento futuro dei dividendi 1.2% Crescita dei dividendi 29.2% Prossima data di pagamento dei dividendi n/a Data di stacco del dividendo n/a Dividendo per azione CN¥1.800 Rapporto di remunerazione 83%
Aggiornamenti recenti su dividendi e riacquisti
Asymchem Laboratories (Tianjin) Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 28 June 2024 Jun 25 Asymchem Laboratories (Tianjin) Co., Ltd. Approves Final Ordinary Dividend for the Year Ended 31 December 2023, Payable on 12 July 2024 Jun 08
Asymchem Laboratories (Tianjin) Co., Ltd. Proposes Final Ordinary Dividend for the Year Ended 31 December 2023 Mar 28 Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821) commences an Equity Buyback Plan for CNY 1,200 million worth of its shares, under the authorization approved on February 29,2024. Mar 09
Asymchem Laboratories (Tianjin) Co., Ltd. Implements Final Cash Dividend (A shares) for 2022, Payable on 21 July 2023 Jun 21
Asymchem Laboratories (Tianjin) Co., Ltd. Declares Final Dividend for the Year Ended 31 December 2022. Payable on 21 July 2023 Jun 10
Mostra tutti gli aggiornamenti Asymchem Creates an Artificial Intelligence Platform to Address Key Challenges in Protein Design Nov 07
Third quarter 2024 earnings released: EPS: CN¥0.61 (vs CN¥1.45 in 3Q 2023) Oct 30
Investor sentiment deteriorates as stock falls 16% Oct 15
Executive VP & Executive Director recently bought CN¥1.8m worth of stock Oct 15
Asymchem Laboratories (Tianjin) Co., Ltd. to Report Q3, 2024 Results on Oct 30, 2024 Sep 30
Investor sentiment improves as stock rises 19% Sep 28
CFO, Senior VP & Executive Director recently bought CN¥4.3m worth of stock Sep 18
Second quarter 2024 earnings released: EPS: CN¥0.63 (vs CN¥2.94 in 2Q 2023) Aug 29
Asymchem Laboratories (Tianjin) Co., Ltd. to Report First Half, 2024 Results on Aug 31, 2024 Jun 29
Dividend of CN¥1.80 announced Jun 27
Asymchem Appoints Cheng Yi Chen as CTO of Small-Molecule Sector Jun 26
Asymchem Laboratories (Tianjin) Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 28 June 2024 Jun 25 Asymchem Laboratories (Tianjin) Co., Ltd. Approves Final Ordinary Dividend for the Year Ended 31 December 2023, Payable on 12 July 2024 Jun 08
Asymchem Appoints Franck Mevellec as Senior Director, Business Development May 30
New major risk - Revenue and earnings growth Apr 01
Asymchem Laboratories (Tianjin) Co., Ltd. to Report Q1, 2024 Results on Apr 26, 2024 Mar 30 Asymchem Laboratories (Tianjin) Co., Ltd., Annual General Meeting, Jun 06, 2024
Asymchem Laboratories (Tianjin) Co., Ltd. Proposes Final Ordinary Dividend for the Year Ended 31 December 2023 Mar 28 Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821) commences an Equity Buyback Plan for CNY 1,200 million worth of its shares, under the authorization approved on February 29,2024. Mar 09
Asymchem Laboratories (Tianjin) Co., Ltd. Appoints Hou Xinyi as an Independent Non-Executive Director, Effective 29 February 2024 Feb 29
Asymchem Laboratories (Tianjin) Co., Ltd. Announces Resignation of Wang Qingsong as Independent Non-Executive Director and Committees Feb 05
Asymchem Laboratories (Tianjin) Co., Ltd. to Report Fiscal Year 2023 Results on Mar 29, 2024 Dec 29
New major risk - Revenue and earnings growth Dec 12
Now 23% undervalued after recent price drop Dec 04
New minor risk - Share price stability Nov 09
Third quarter 2023 earnings released: EPS: CN¥1.45 (vs CN¥2.71 in 3Q 2022) Oct 31
Asymchem Laboratories (Tianjin) Co., Ltd. Appoints Sun Xuejiao as Independent Non-Executive Director Sep 14
New major risk - Revenue and earnings growth Sep 02
Second quarter 2023 earnings released: EPS: CN¥2.94 (vs CN¥3.39 in 2Q 2022) Aug 30
Asymchem Laboratories (Tianjin) Co., Ltd. Implements Final Cash Dividend (A shares) for 2022, Payable on 21 July 2023 Jun 21
Asymchem Laboratories (Tianjin) Co., Ltd. Declares Final Dividend for the Year Ended 31 December 2022. Payable on 21 July 2023 Jun 10
Full year 2022 earnings released: EPS: CN¥9.02 (vs CN¥3.15 in FY 2021) Mar 31 Asymchem Laboratories (Tianjin) Co., Ltd. to Report Fiscal Year 2022 Results on Mar 31, 2023
Asymchem Laboratories (Tianjin) Co., Ltd. Announces Resignation of Zhang Kun as an Independent Non-Executive Director Jan 17
Less than half of directors are independent Nov 16
Third quarter 2022 earnings released: EPS: CN¥2.71 (vs CN¥0.79 in 3Q 2021) Oct 28
Investor sentiment deteriorated over the past week Sep 17
Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821) commences an Equity Buyback Plan for CNY 800 million worth of its shares, under the authorization approved on September 2, 2022. Sep 07
Second quarter 2022 earnings released: EPS: CN¥3.38 (vs CN¥0.81 in 2Q 2021) Aug 26
Asymchem Laboratories (Tianjin) Co., Ltd. to Report First Half, 2022 Results on Aug 25, 2022 Aug 16 Asymchem Laboratories (Tianjin) Co., Ltd. Provides Earnings Guidance for the Period Ended June 30, 2022
Now 27% undervalued after recent price drop Jul 13
Asymchem Laboratories (Tianjin) Co., Ltd. Approves Cash Dividend for the Year 2021 Jun 11
Now 21% undervalued after recent price drop May 26
Asymchem Laboratories (Tianjin) Co., Ltd. Proposes Final Dividend for the Year Ended 31 December 2021, Payable on 21 July 2022 May 14
Less than half of directors are independent Apr 27
Asymchem Laboratories (Tianjin) Co., Ltd., Annual General Meeting, Jun 09, 2022 Apr 21
Asymchem Laboratories (Tianjin) Co., Ltd. to Report Q1, 2022 Results on Apr 20, 2022 Apr 07
Asymchem Laboratories (Tianjin) Co., Ltd. Proposes Final Cash Dividend for the Year Ended December 31, 2021 Apr 01
Asymchem Laboratories (Tianjin) Co., Ltd. Announces Final Dividend for the Year Ended December 31, 2021 Mar 31
Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821) entered into an agreement to acquire remaining 81.82% stake in Snapdragon Chemistry, Inc. for $57.9 million. Feb 12
Investor sentiment deteriorated over the past week Feb 12
Asymchem Laboratories (Tianjin) Co., Ltd. Provides Group Earnings Guidance for the Year Ending December 31, 2021 Jan 26
Less than half of directors are independent Jan 21
Asymchem Laboratories (Tianjin) Co., Ltd. has filed an IPO in the amount of HKD 7.550314 billion. Dec 01
Asymchem Laboratories (Tianjin) Co., Ltd. Announces Dividend for 2020 May 21
First quarter 2021 earnings released: EPS CN¥0.64 (vs CN¥0.47 in 1Q 2020) Apr 26
Asymchem Laboratories (Tianjin) Co., Ltd. to Report Fiscal Year 2020 Results on Apr 16, 2021 Mar 09
New 90-day low: CN¥256 Mar 05
Asymchem Laboratories (Tianjin) Co., Ltd. Elects Zhang Ting as Non-Independent Director Feb 11
New 90-day high: CN¥316 Jan 20
New 90-day high: CN¥297 Dec 25
New 90-day high: CN¥288 Nov 09
Asymchem Laboratories (Tianjin) Co., Ltd. to Report Q3, 2020 Results on Oct 24, 2020 Oct 17
New 90-day high: CN¥274 Oct 12
Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821) signed an equity transfer agreement to acquire Tianjin Guanqin Pharmaceutical Technology Co., Ltd. from Tianjin Shengqin Pharmaceutical Technology Partnership (Limited Partnership) and Liang Qing for CNY 30 million. Sep 10
New 90-day high - CN¥250 Aug 21
Asymchem Laboratories (Tianjin) Co., Ltd. to Report First Half, 2020 Results on Aug 08, 2020 Jul 18
Stabilità e crescita dei pagamenti
Recupero dei dati sui dividendi
Dividendo stabile: Sebbene i pagamenti dei dividendi siano rimasti stabili, 002821 paga dividendi da meno di 10 anni.
Dividendo in crescita: I pagamenti dei dividendi di 002821 sono aumentati, ma la società ha pagato dividendi solo per 7 anni.
Rendimento dei dividendi rispetto al mercato Asymchem Laboratories (Tianjin) Rendimento dei dividendi rispetto al mercato
Come si colloca il rendimento da dividendo di 002821 rispetto al mercato? Segmento Rendimento dei dividendi Azienda (002821) 2.0% Fondo del 25% del mercato (CN) 0.5% Top 25% del mercato (CN) 2.1% Media del settore (Pharmaceuticals) 1.6% Analista previsionale (002821) (fino a 3 anni) 1.2%
Dividendo notevole: Il dividendo di 002821 ( 1.97% ) è più alto rispetto al 25% inferiore dei pagatori di dividendi nel mercato CN ( 0.51% ).
Dividendo elevato: Il dividendo di 002821 ( 1.97% ) è basso rispetto al 25% dei maggiori pagatori di dividendi nel mercato CN ( 2.06%.
Distribuzione degli utili agli azionisti
Copertura degli utili: Al suo attuale payout ratio ( 83.3% ), i pagamenti di 002821 sono coperti dagli utili.
Pagamenti in contanti agli azionisti
Copertura del flusso di cassa: Con il suo elevato cash payout ratio ( 149.4% ), i pagamenti dei dividendi di 002821 non sono ben coperti dai flussi di cassa.
Scoprire le società che pagano dividendi forti Simply Wall St™ Simply Wall Street Pty Ltd Level 7, 320 Pitt Street, Sydney Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"control","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}